Long-Term Effects of Severe Burns on the Kidneys: Research Advances and Potential Therapeutic Approaches

References

• World Health Organization. Burns; 2018.
   Google Scholar
• Folkestad T, Brurberg KG, Nordhuus KM, et al. Acute kidney injury in burn patients admitted to the intensive care unit: a systematic review and meta-analysis. Crit Care. 2020;24(1):2.
   PubMed Web of Science ®Google Scholar
• Clark A, Neyra JA, Madni T, et al. Acute kidney injury after burn. Burns. 2017;43(5):898–908.
   PubMed Web of Science ®Google Scholar
• Chen B, Zhao J, Zhang Z, et al. Clinical characteristics and risk factors for severe burns complicated by early acute kidney injury. Burns. 2020;46(5):1100–1106.
   PubMed Web of Science ®Google Scholar
• Helanterä I, Koljonen V, Finne P, Tukiainen E, Gissler M. The risk for end-stage renal disease is increased after burn. Burns. 2016;42(2):316–321.
   PubMed Web of Science ®Google Scholar
• Leung KC, Tonelli M, James MT. Chronic kidney disease following acute kidney injury-risk and outcomes. Nat Rev Nephrol. 2013;9(2):77–85.
   PubMed Web of Science ®Google Scholar
• Sato Y, Yanagita M. Immune cells and inflammation in AKI to CKD progression. Am J Physiol Renal Physiol. 2018;315(6):F1501–f1512.
   PubMed Web of Science ®Google Scholar
• He L, Wei Q, Liu J, et al. AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms. Kidney Int. 2017;92(5):1071–1083.
   PubMed Web of Science ®Google Scholar
• Kurzhagen JT, Dellepiane S, Cantaluppi V, Rabb H. AKI: an increasingly recognized risk factor for CKD development and progression. J Nephrol. 2020;33(6):1171–1187.
   PubMed Web of Science ®Google Scholar
• Rayego-Mateos S, Marquez-Expósito L, Rodrigues-Diez R, et al. Molecular mechanisms of kidney injury and repair. Int J Mol Sci. 2022;23(3):1.
   Web of Science ®Google Scholar
• Gao L, Zhong X, Jin J, Li J, Meng XM. Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression. Signal Transduct Target Ther. 2020;5(1):9.
   PubMed Web of Science ®Google Scholar
• Wang M, Yao S, He D, et al. Type 2 diabetic mellitus inhibits skin renewal through inhibiting wnt-dependent Lgr5+ hair follicle stem cell activation in C57BL/6 mice. J Diabetes Res. 2022;2022:8938276.
   PubMed Web of Science ®Google Scholar
• Yun CW, Lee SH. Potential and therapeutic efficacy of cell-based therapy using mesenchymal stem cells for acute/chronic kidney disease. Int J Mol Sci. 2019;20:7.
   Web of Science ®Google Scholar
• Zhang Y, Wang C, Bai Z, Li P. Umbilical cord mesenchymal stem cell exosomes alleviate the progression of kidney failure by modulating inflammatory responses and oxidative stress in an ischemia-reperfusion mice model. J Biomed Nanotechnol. 2021;17(9):1874–1881.
   PubMed Web of Science ®Google Scholar
• Zhang Z-W, Wei P, Zhang G-J, et al. Intravenous infusion of the exosomes derived from human umbilical cord mesenchymal stem cells enhance neurological recovery after traumatic brain injury via suppressing the NF-κB pathway. Open Life Sci. 2022;17(1):189–201.
   PubMed Web of Science ®Google Scholar
• Cao Q, Huang C, Chen XM, Pollock CA. Mesenchymal stem cell-derived exosomes: toward cell-free therapeutic strategies in chronic kidney disease. Front Med. 2022;9:816656.
   Web of Science ®Google Scholar
• Levey AS. Defining AKD: the Spectrum of AKI, AKD, and CKD. Nephron. 2022;146(3):302–305.
   PubMed Web of Science ®Google Scholar
• Niculae A, Peride I, Tiglis M, et al. Burn-induced acute kidney injury-two-lane road: from molecular to clinical aspects. Int J Mol Sci. 2022;23:15.
   Google Scholar
• Wu G, Xiao Y, Wang C, et al. Risk factors for acute kidney injury in patients with burn injury: a meta-analysis and systematic review. J Burn Care Res. 2017;38(5):271–282.
   PubMed Web of Science ®Google Scholar
• You B, Yang Z, Zhang Y, et al. Late-onset acute kidney injury is a poor prognostic sign for severe burn patients. Front Surg. 2022;9:842999.
   PubMedGoogle Scholar
• Colpaert K, Hoste EA. Acute kidney injury in burns: a story of volume and inflammation. Crit Care. 2008;12(6):192.
   PubMed Web of Science ®Google Scholar
• Jeschke MG, Mlcak RP, Finnerty CC, et al. Burn size determines the inflammatory and hypermetabolic response. Crit Care. 2007;11(4):R90.
   PubMed Web of Science ®Google Scholar
• Wan L, Bellomo R, Di Giantomasso D, Ronco C. The pathogenesis of septic acute renal failure. Curr Opin Crit Care. 2003;9(6):496–502.
   PubMedGoogle Scholar
• Tan BK, Liew ZH, Kaushik M, Cheah AKW, Tan HK. Early initiation of renal replacement therapy among burned patients with acute kidney injury. Ann Plast Surg. 2020;84(4):375–378.
   PubMed Web of Science ®Google Scholar
• Su CL, Chang GH, Tsai IJ, Hsu CY, Wang IK, Chang CC. Factors impacting survival in patients with major burn-induced acute kidney injury postrenal replacement therapy: a nationwide study with 15 years follow-up in Taiwan. Ann Plast Surg. 2021;86(2S Suppl 1):S23–s29.
   PubMed Web of Science ®Google Scholar
• Xu M, Zhao M, Zheng D. Effect of IGF-1C domain-modified nanoparticles on renal ischemia-reperfusion injury in mice. Ren Fail. 2022;44(1):1376–1387.
   PubMed Web of Science ®Google Scholar
• Wu H, Meng G, Zuo C, et al. The Effects of sodium bicarbonate Ringer’s solution on acute kidney injury and the clinical outcomes after liver transplantation: a randomized controlled trial. Front Pharmacol. 2022;13:982472.
   PubMedGoogle Scholar
• Silbert BI, Ho KM, Lipman J, et al. Does furosemide increase oxidative stress in acute kidney injury? Antioxid Redox Signal. 2017;26(5):221–226.
   PubMed Web of Science ®Google Scholar
• Shi J, Chen C, Li J, Shi T, Zhang G, Ke J. Pathological observation of kidneys in severe burn death cases. Peoples Lib Army Med J. 1983;167(1):49–52.
   Google Scholar
• Gigliotti JC, Tin A, Pourafshar S, et al. GSTM1 deletion exaggerates kidney injury in experimental mouse models and confers the protective effect of cruciferous vegetables in mice and humans. J Am Soc Nephrol. 2020;31(1):102–116.
   PubMed Web of Science ®Google Scholar
• Hering L, Rahman M, Hoch H, et al. Alpha2A-adrenoceptors modulate renal sympathetic neurotransmission and protect against hypertensive kidney disease. J Am Soc Nephrol. 2020;31(4):783–798.
   PubMed Web of Science ®Google Scholar
• Palackic A, Suman OE, Porter C, Murton AJ, Crandall CG, Rivas E. Rehabilitative exercise training for burn injury. Sports Med. 2021;51(12):2469–2482.
   PubMed Web of Science ®Google Scholar
• Mariano F, De Biase C, Hollo Z, et al. Long-term preservation of renal function in septic shock burn patients requiring renal replacement therapy for acute kidney injury. J Clin Med. 2021;10:24.
   Web of Science ®Google Scholar
• Mariano F, Cantaluppi V, Stella M, et al. Circulating plasma factors induce tubular and glomerular alterations in septic burns patients. Crit Care. 2008;12(2):R42.
   PubMed Web of Science ®Google Scholar
• Oudemans-van Straaten HM. Circulating pro-apoptotic mediators in burn septic acute renal failure. Crit Care. 2008;12(2):126.
   PubMed Web of Science ®Google Scholar
• Wu VC, Chan CK, Chueh JS, et al. Markers of kidney tubular function deteriorate while those of kidney tubule health improve in primary aldosteronism after targeted treatments. J Am Heart Assoc. 2023;12(4):e028146.
   PubMed Web of Science ®Google Scholar
• Soltani A, Karsidag S, Garner W. A ten-year experience with hemodialysis in burn patients at Los Angeles County + USC Medical Center. J Burn Care Res. 2009;30(5):832–835.
   PubMed Web of Science ®Google Scholar
• Thalji SZ, Kothari AN, Kuo PC, Mosier MJ. Acute kidney injury in burn patients: clinically significant over the initial hospitalization and 1 year after injury: an original retrospective cohort study. Ann Surg. 2017;266(2):376–382.
   PubMed Web of Science ®Google Scholar
• Duan Z, Cai G, Li J, Chen F, Chen X. Meta-analysis of renal replacement therapy for burn patients: incidence rate, mortality, and renal outcome. Front Med. 2021;8:708533.
   Google Scholar
• Mulder PPG, Vlig M, Boekema B, et al. Persistent systemic inflammation in patients with severe burn injury is accompanied by influx of immature neutrophils and shifts in T cell subsets and cytokine profiles. Front Immunol. 2020;11:621222.
   PubMed Web of Science ®Google Scholar
• Knuth CM, Auger C, Jeschke MG. Burn-induced hypermetabolism and skeletal muscle dysfunction. Am J Physiol Cell Physiol. 2021;321(1):C58–c71.
   PubMed Web of Science ®Google Scholar
• Jeschke MG, Gauglitz GG, Kulp GA, et al. Long-term persistance of the pathophysiologic response to severe burn injury. PLoS One. 2011;6(7):e21245.
   PubMed Web of Science ®Google Scholar
• Denic A, Glassock RJ, Rule AD. Structural and functional changes with the aging kidney. Adv Chronic Kidney Dis. 2016;23(1):19–28.
   PubMed Web of Science ®Google Scholar
• Guzzi F, Cirillo L, Roperto RM, Romagnani P, Lazzeri E. Molecular mechanisms of the acute kidney injury to chronic kidney disease transition: an updated view. Int J Mol Sci. 2019;20:19.
   Web of Science ®Google Scholar
• Tan HL, Yap JQ, Qian Q. Acute kidney injury: tubular markers and risk for chronic kidney disease and end-stage kidney failure. Blood Purif. 2016;41(1–3):144–150.
   PubMed Web of Science ®Google Scholar
• Fiorentino M, Grandaliano G, Gesualdo L, Castellano G. Acute kidney injury to chronic kidney disease transition. Contrib Nephrol. 2018;193:45–54.
   PubMed Web of Science ®Google Scholar
• Hu MC, Shi M, Gillings N, et al. Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy. Kidney Int. 2017;91(5):1104–1114.
   PubMed Web of Science ®Google Scholar
• Heung M, Chawla LS. Predicting progression to chronic kidney disease after recovery from acute kidney injury. Curr Opin Nephrol Hypertens. 2012;21(6):628–634.
   PubMed Web of Science ®Google Scholar
• Shiva N, Sharma N, Kulkarni YA, Mulay SR, Gaikwad AB. Renal ischemia/reperfusion injury: an insight on in vitro and in vivo models. Life Sci. 2020;256:117860.
   PubMed Web of Science ®Google Scholar
• Chen JH, Chao CT, Huang JW, et al. Early elimination of uremic toxin ameliorates AKI-to-CKD transition. Clin Sci. 2021;135(23):2643–2658.
   Web of Science ®Google Scholar
• Cortinovis M, Perico N, Ruggenenti P, Remuzzi A, Remuzzi G. Glomerular hyperfiltration. Nat Rev Nephrol. 2022;18(7):435–451.
   PubMed Web of Science ®Google Scholar
• Barrera-Chimal J, Rocha L, Amador-Martínez I, et al. Delayed spironolactone administration prevents the transition from acute kidney injury to chronic kidney disease through improving renal inflammation. Nephrol Dial Transplant. 2019;34(5):794–801.
   PubMed Web of Science ®Google Scholar
• Polichnowski AJ. Microvascular rarefaction and hypertension in the impaired recovery and progression of kidney disease following AKI in preexisting CKD states. Am J Physiol Renal Physiol. 2018;315(6):F1513–f1518.
   PubMed Web of Science ®Google Scholar
• Bellomo R, Wan L, Langenberg C, Ishikawa K, May CN. Septic acute kidney injury: the glomerular arterioles. Contrib Nephrol. 2011;174:98–107.
   PubMed Web of Science ®Google Scholar
• Calzavacca P, May CN, Bellomo R. Glomerular haemodynamics, the renal sympathetic nervous system and sepsis-induced acute kidney injury. Nephrol Dial Transplant. 2014;29(12):2178–2184.
   PubMed Web of Science ®Google Scholar
• Chou YH, Chu TS, Lin SL. Role of renin-angiotensin system in acute kidney injury-chronic kidney disease transition. Nephrology. 2018;23(Suppl 4):121–125.
   PubMedGoogle Scholar
• Maekawa H, Inagi R. Pathophysiological role of organelle stress/crosstalk in AKI-to-CKD Transition. Semin Nephrol. 2019;39(6):581–588.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhang C. From AKI to CKD: maladaptive repair and the underlying mechanisms. Int J Mol Sci. 2022;23(18):5.
   Web of Science ®Google Scholar
• Black LM, Lever JM, Traylor AM, et al. Divergent effects of AKI to CKD models on inflammation and fibrosis. Am J Physiol Renal Physiol. 2018;315(4):F1107–f1118.
   PubMed Web of Science ®Google Scholar
• Li Z, Li N. Epigenetic modification drives acute kidney injury-to-chronic kidney disease progression. Nephron. 2021;145(6):737–747.
   PubMed Web of Science ®Google Scholar
• Zuk A, Bonventre JV. Recent advances in acute kidney injury and its consequences and impact on chronic kidney disease. Curr Opin Nephrol Hypertens. 2019;28(4):397–405.
   PubMed Web of Science ®Google Scholar
• Basile DP, Collett JA. Orai1: a new therapeutic target for the acute kidney injury-to-chronic kidney disease transition. Nephron. 2022;146(3):264–267.
   PubMed Web of Science ®Google Scholar
• Meng X, Jin J, Lan HY. Driving role of macrophages in transition from acute kidney injury to chronic kidney disease. Chin Med J. 2022;135(7):757–766.
   PubMed Web of Science ®Google Scholar
• Zhang J, Rudemiller NP, Patel MB, et al. Competing actions of type 1 angiotensin II receptors expressed on T lymphocytes and kidney epithelium during cisplatin-induced AKI. J Am Soc Nephrol. 2016;27(8):2257–2264.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Romo R, Benítez K, Barrera-Chimal J, et al. AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney disease. Kidney Int. 2016;89(2):363–373.
   PubMed Web of Science ®Google Scholar
• Barrera-Chimal J, Pérez-Villalva R, Rodríguez-Romo R, et al. Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury. Kidney Int. 2013;83(1):93–103.
   PubMed Web of Science ®Google Scholar
• Barrera-Chimal J, Prince S, Fadel F, et al. Sulfenic acid modification of endothelin B receptor is responsible for the benefit of a nonsteroidal mineralocorticoid receptor antagonist in renal ischemia. J Am Soc Nephrol. 2016;27(2):398–404.
   PubMed Web of Science ®Google Scholar
• Cheng SY, Chou YH, Liao FL, et al. Losartan reduces ensuing chronic kidney disease and mortality after acute kidney injury. Sci Rep. 2016;6:34265.
   PubMed Web of Science ®Google Scholar
• Cao W, Jin L, Zhou Z, et al. Overexpression of intrarenal renin-angiotensin system in human acute tubular necrosis. Kidney Blood Press Res. 2016;41(6):746–756.
   PubMed Web of Science ®Google Scholar
• Chen C, Yang X, Lei Y, et al. Urinary biomarkers at the time of AKI diagnosis as predictors of progression of AKI among patients with acute cardiorenal syndrome. Clin J Am Soc Nephrol. 2016;11(9):1536–1544.
   PubMed Web of Science ®Google Scholar
• Hsu CY, Hsu RK, Yang J, Ordonez JD, Zheng S, Go AS. Elevated BP after AKI. J Am Soc Nephrol. 2016;27(3):914–923.
   PubMed Web of Science ®Google Scholar
• Benedetto U, Melina G, Capuano F, et al. Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery. J Cardiovasc Med. 2008;9(11):1098–1103.
   Google Scholar
• Arora P, Rajagopalam S, Ranjan R, et al. Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clin J Am Soc Nephrol. 2008;3(5):1266–1273.
   PubMed Web of Science ®Google Scholar
• Anders HJ. Immune system modulation of kidney regeneration--mechanisms and implications. Nat Rev Nephrol. 2014;10(6):347–358.
   PubMed Web of Science ®Google Scholar
• Anders HJ, Ryu M. Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney Int. 2011;80(9):915–925.
   PubMed Web of Science ®Google Scholar
• Basile DP, Bonventre JV, Mehta R, et al. Progression after AKI: understanding maladaptive repair processes to predict and identify therapeutic treatments. J Am Soc Nephrol. 2016;27(3):687–697.
   PubMed Web of Science ®Google Scholar
• Jiang M, Bai M, Lei J, et al. Mitochondrial dysfunction and the AKI-to-CKD transition. Am J Physiol Renal Physiol. 2020;319(6):F1105–f1116.
   PubMed Web of Science ®Google Scholar
• Sato Y, Takahashi M, Yanagita M. Pathophysiology of AKI to CKD progression. Semin Nephrol. 2020;40(2):206–215.
   PubMed Web of Science ®Google Scholar
• Liu Z, Wang Y, Shu S, Cai J, Tang C, Dong Z. Non-coding RNAs in kidney injury and repair. Am J Physiol Cell Physiol. 2019;317(2):C177–c188.
   PubMed Web of Science ®Google Scholar
• De Chiara L, Conte C, Antonelli G, Lazzeri E. Tubular cell cycle response upon AKI: revising old and new paradigms to identify novel targets for CKD prevention. Int J Mol Sci. 2021;22:20.
   Web of Science ®Google Scholar
• Zhang X, Agborbesong E, Li X. The role of mitochondria in acute kidney injury and chronic kidney disease and its therapeutic potential. Int J Mol Sci. 2021;22:20.
   Google Scholar
• Szeto HH. Pharmacologic approaches to improve mitochondrial function in AKI and CKD. J Am Soc Nephrol. 2017;28(10):2856–2865.
   PubMed Web of Science ®Google Scholar
• Cao C, Yao Y, Zeng R. Lymphocytes: versatile participants in acute kidney injury and progression to chronic kidney disease. Front Physiol. 2021;12:729084.
   PubMed Web of Science ®Google Scholar
• Baligand C, Qin H, True-Yasaki A, et al. Hyperpolarized (13) C magnetic resonance evaluation of renal ischemia reperfusion injury in a murine model. NMR Biomed. 2017;30:10.
   Web of Science ®Google Scholar
• Lan R, Geng H, Singha PK, et al. Mitochondrial pathology and glycolytic shift during proximal tubule atrophy after ischemic AKI. J Am Soc Nephrol. 2016;27(11):3356–3367.
   PubMed Web of Science ®Google Scholar
• Funk JA, Schnellmann RG. Persistent disruption of mitochondrial homeostasis after acute kidney injury. Am J Physiol Renal Physiol. 2012;302(7):F853–864.
   PubMed Web of Science ®Google Scholar
• De Chiara L, Conte C, Semeraro R, et al. Tubular cell polyploidy protects from lethal acute kidney injury but promotes consequent chronic kidney disease. Nat Commun. 2022;13(1):5805.
   PubMed Web of Science ®Google Scholar
• Inoue T, Kusano T, Amano H, Nakamoto H, Okada H. Cellular communication network factor 2 (CCN2) promotes the progression of acute kidney injury to chronic kidney disease. Biochem Biophys Res Commun. 2019;517(1):96–102.
   PubMed Web of Science ®Google Scholar
• Chen J, Lu H, Wang X, et al. VNN1 contributes to the acute kidney injury-chronic kidney disease transition by promoting cellular senescence via affecting RB1 expression. FASEB j. 2022;36(9):e22472.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Hu J, Chen Z, et al. Transition of acute kidney injury to chronic kidney disease: role of metabolic reprogramming. Metabolism. 2022;131:155194.
   PubMed Web of Science ®Google Scholar
• Zhang H, Qu W, Nazzal M, Ortiz J. Burn patients with history of kidney transplant experience increased incidence of wound infection. Burns. 2020;46(3):609–615.
   PubMed Web of Science ®Google Scholar
• Knowlin LT, Purcell L, Cairns BA, Charles AG. Burn injury mortality in patients with preexisting and new onset renal disease. Am J Surg. 2018;215(6):1011–1015.
   PubMed Web of Science ®Google Scholar
• Brusselaers N, Monstrey S, Colpaert K, Decruyenaere J, Blot SI, Hoste EA. Outcome of acute kidney injury in severe burns: a systematic review and meta-analysis. Intensive Care Med. 2010;36(6):915–925.
   PubMed Web of Science ®Google Scholar
• Ronco C, Bellomo R, Kellum J. Understanding renal functional reserve. Intensive Care Med. 2017;43(6):917–920.
   PubMed Web of Science ®Google Scholar
• Hoste EAJ, Kellum JA, Selby NM, et al. Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol. 2018;14(10):607–625.
   PubMed Web of Science ®Google Scholar
• Lin X, Jin H, Chai Y, Shou S. Cellular senescence and acute kidney injury. Pediatr Nephrol. 2022;37(12):3009–3018.
   PubMed Web of Science ®Google Scholar
• Ishani A, Xue JL, Himmelfarb J, et al. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol. 2009;20(1):223–228.
   PubMed Web of Science ®Google Scholar
• Schmitt R, Cantley LG. The impact of aging on kidney repair. Am J Physiol Renal Physiol. 2008;294(6):F1265–1272.
   PubMed Web of Science ®Google Scholar
• Franzin R, Stasi A, Fiorentino M, et al. Inflammaging and complement system: a link between acute kidney injury and chronic graft damage. Front Immunol. 2020;11:734.
   PubMed Web of Science ®Google Scholar
• Yang L, Besschetnova TY, Brooks CR, Shah JV, Bonventre JV. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med. 2010;16(5):535–543, 531p following 143.
   PubMed Web of Science ®Google Scholar
• Grgic I, Campanholle G, Bijol V, et al. Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis. Kidney Int. 2012;82(2):172–183.
   PubMed Web of Science ®Google Scholar
• Basile DP, Donohoe D, Roethe K, Osborn JL. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol. 2001;281(5):F887–899.
   PubMed Web of Science ®Google Scholar
• Ferenbach DA, Bonventre JV. Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD. Nat Rev Nephrol. 2015;11(5):264–276.
   PubMed Web of Science ®Google Scholar
• Zhu M, Zhu M, Wu X, et al. Porcine acellular dermal matrix increases fat survival rate after fat grafting in nude mice. Aesthetic Plast Surg. 2021;2021:1.
   Google Scholar
• Meng F, Qiu J, Chen H, et al. Dietary supplementation with N‐3 polyunsaturated fatty acid‐enriched fish oil promotes wound healing after ultraviolet B‐induced sunburn in mice. Food Sci Nutri. 2021;00:1–8.
   Google Scholar
• Hammer A, Yang G, Friedrich J, et al. Role of the receptor Mas in macrophage-mediated inflammation in vivo. Proc Natl Acad Sci USA. 2016;113(49):14109–14114.
   PubMed Web of Science ®Google Scholar
• Hering L, Rahman M, Potthoff SA, Rump LC, Stegbauer J. Role of α2-adrenoceptors in hypertension: focus on renal sympathetic neurotransmitter release, inflammation, and sodium homeostasis. Front Physiol. 2020;11:566871.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang H, Chen Q, et al. TNF-alpha/HMGB1 inflammation signalling pathway regulates pyroptosis during liver failure and acute kidney injury. Cell Prolif. 2020;53(6):e12829.
   PubMed Web of Science ®Google Scholar
• Gibson BHY, Wollenman CC, Moore-Lotridge SN, et al. Plasmin drives burn-induced systemic inflammatory response syndrome. JCI Insight. 2021;6:23.
   Web of Science ®Google Scholar
• Li Y, Zhang H, Chen C, et al. Biomimetic immunosuppressive exosomes that inhibit cytokine storms contribute to the alleviation of sepsis. Adv Mater. 2022;34(19):e2108476.
   PubMed Web of Science ®Google Scholar
• Kraft R, Herndon DN, Finnerty CC, Shahrokhi S, Jeschke MG. Occurrence of multiorgan dysfunction in pediatric burn patients: incidence and clinical outcome. Ann Surg. 2014;259(2):381–387.
   PubMed Web of Science ®Google Scholar
• Ohta H, Liu X, Maeda M. Autologous adipose mesenchymal stem cell administration in arteriosclerosis and potential for anti-aging application: a retrospective cohort study. Stem Cell Res Ther. 2020;11(1):538.
   PubMed Web of Science ®Google Scholar
• Tögel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol. 2005;289(1):F31–42.
   PubMed Web of Science ®Google Scholar
• Morigi M, Imberti B, Zoja C, et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol. 2004;15(7):1794–1804.
   PubMed Web of Science ®Google Scholar
• Markov A, Thangavelu L, Aravindhan S, et al. Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders. Stem Cell Res Ther. 2021;12(1):192.
   PubMed Web of Science ®Google Scholar
• Gao J, Gao C. Development and regulation of stem cell-based therapies in China. Cell Prolif. 2022;55(8):e13217.
   PubMed Web of Science ®Google Scholar
• Cao H, Qian H, Xu W, et al. Mesenchymal stem cells derived from human umbilical cord ameliorate ischemia/reperfusion-induced acute renal failure in rats. Biotechnol Lett. 2010;32(5):725–732.
   PubMed Web of Science ®Google Scholar
• Fahmy SR, Soliman AM, El Ansary M, Elhamid SA, Mohsen H. Therapeutic efficacy of human umbilical cord mesenchymal stem cells transplantation against renal ischemia/reperfusion injury in rats. Tissue Cell. 2017;49(3):369–375.
   PubMed Web of Science ®Google Scholar
• Peng X, Xu H, Zhou Y, et al. Human umbilical cord mesenchymal stem cells attenuate cisplatin-induced acute and chronic renal injury. Exp Biol Med. 2013;238(8):960–970.
   PubMed Web of Science ®Google Scholar
• Xu Q, Yan P, Duan XJ, et al. Human umbilical cord-derived mesenchymal stem cells and human cord blood mononuclear cells protect against cisplatin-induced acute kidney injury in rat models. Exp Ther Med. 2020;20(6):145.
   PubMed Web of Science ®Google Scholar
• Xiang J, Jiang T, Zhang W, Xie W, Tang X, Zhang J. Human umbilical cord-derived mesenchymal stem cells enhanced HK-2 cell autophagy through MicroRNA-145 by inhibiting the PI3K/AKT/mTOR signaling pathway. Exp Cell Res. 2019;378(2):198–205.
   PubMed Web of Science ®Google Scholar
• Fazekas B, Alagesan S, Watson L, et al. Comparison of single and repeated dosing of anti-inflammatory human umbilical cord mesenchymal stromal cells in a mouse model of polymicrobial sepsis. Stem Cell Rev Rep. 2022;18(4):1444–1460.
   PubMed Web of Science ®Google Scholar
• Yang G, Waheed S, Wang C, Shekh M, Li Z, Wu J. Exosomes and their bioengineering strategies in the cutaneous wound healing and related complications: current knowledge and future perspectives. Int J Biol Sci. 2023;19(5):1430–1454.
   PubMedGoogle Scholar
• Yuan L, Wu MJ, Sun HY, et al. VEGF-modified human embryonic mesenchymal stem cell implantation enhances protection against cisplatin-induced acute kidney injury. Am J Physiol Renal Physiol. 2011;300(1):F207–218.
   PubMed Web of Science ®Google Scholar
• Chen Y, Qian H, Zhu W, et al. Hepatocyte growth factor modification promotes the amelioration effects of human umbilical cord mesenchymal stem cells on rat acute kidney injury. Stem Cells Dev. 2011;20(1):103–113.
   PubMed Web of Science ®Google Scholar
• Park HJ, Kong MJ, Jang HJ, et al. A nonbiodegradable scaffold-free cell sheet of genome-engineered mesenchymal stem cells inhibits development of acute kidney injury. Kidney Int. 2021;99(1):117–133.
   PubMed Web of Science ®Google Scholar
• Hu Q, Lyon CJ, Fletcher JK, Tang W, Wan M, Hu TY. Extracellular vesicle activities regulating macrophage- and tissue-mediated injury and repair responses. Acta Pharm Sin B. 2021;11(6):1493–1512.
   PubMed Web of Science ®Google Scholar
• Wan F, Yang RC, Tang YW, et al. BMSC-derived exosomes protect against kidney injury through regulating klotho in 5/6 nephrectomy rats. Eur J Med Res. 2022;27(1):118.
   PubMed Web of Science ®Google Scholar
• Aghajani Nargesi A, Lerman LO, Eirin A. Mesenchymal stem cell-derived extracellular vesicles for kidney repair: current status and looming challenges. Stem Cell Res Ther. 2017;8(1):273.
   PubMed Web of Science ®Google Scholar
• Jia H, Liu W, Zhang B, et al. HucMSC exosomes-delivered 14-3-3ζ enhanced autophagy via modulation of ATG16L in preventing cisplatin-induced acute kidney injury. Am J Transl Res. 2018;10(1):101–113.
   PubMed Web of Science ®Google Scholar
• Zhang R, Zhu Y, Li Y, et al. Human umbilical cord mesenchymal stem cell exosomes alleviate sepsis-associated acute kidney injury via regulating microRNA-146b expression. Biotechnol Lett. 2020;42(4):669–679.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Xu H, Xu W, et al. Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro. Stem Cell Res Ther. 2013;4(2):34.
   PubMed Web of Science ®Google Scholar
• Huang J, Cao H, Cui B, et al. Mesenchymal stem cells-derived exosomes ameliorate ischemia/reperfusion induced acute kidney injury in a porcine model. Front Cell Dev Biol. 2022;10:899869.
   PubMed Web of Science ®Google Scholar
• Cao JY, Wang B, Tang TT, et al. Exosomal miR-125b-5p deriving from mesenchymal stem cells promotes tubular repair by suppression of p53 in ischemic acute kidney injury. Theranostics. 2021;11(11):5248–5266.
   PubMed Web of Science ®Google Scholar
• Tsuji K, Kitamura S, Wada J. Secretomes from mesenchymal stem cells against acute kidney injury: possible heterogeneity. Stem Cells Int. 2018;2018:8693137.
   PubMed Web of Science ®Google Scholar
• Racchetti G, Meldolesi J. Extracellular vesicles of mesenchymal stem cells: therapeutic properties discovered with extraordinary success. Biomedicines. 2021;9:6.
   Web of Science ®Google Scholar
• Liu L, Wu Y, Wang P, et al. PSC-MSC-derived exosomes protect against kidney fibrosis in vivo and in vitro through the SIRT6/β-catenin signaling pathway. Int J Stem Cells. 2021;14(3):310–319.
   PubMed Web of Science ®Google Scholar
• Zhu F, Chong Lee Shin OLS, Pei G, et al. Adipose-derived mesenchymal stem cells employed exosomes to attenuate AKI-CKD transition through tubular epithelial cell dependent Sox9 activation. Oncotarget. 2017;8(41):70707–70726.
   PubMedGoogle Scholar
• Yang Y, Wang J, Zhang Y, Hu X, Li L, Chen P. Exosomes derived from mesenchymal stem cells ameliorate renal fibrosis via delivery of miR-186-5p. Hum Cell. 2022;35(1):83–97.
   PubMed Web of Science ®Google Scholar
• Alasmari WA, El-Shetry ES, Ibrahim D, et al. Mesenchymal stem-cells’ exosomes are renoprotective in postmenopausal chronic kidney injury via reducing inflammation and degeneration. Free Radic Biol Med. 2022;182:150–159.
   PubMed Web of Science ®Google Scholar
• Alasmari WA, Abdelfattah-Hassan A, El-Ghazali HM, et al. Exosomes derived from BM-MSCs mitigate the development of chronic kidney damage post-menopause via interfering with fibrosis and apoptosis. Biomolecules. 2022;12:5.
   Web of Science ®Google Scholar
• Wang D, Kang L, Chen C, et al. Loss of legumain induces premature senescence and mediates aging-related renal fibrosis. Aging Cell. 2022;21(3):e13574.
   PubMed Web of Science ®Google Scholar
• Liao CM, Luo T, von der Ohe J, de Juan Mora B, Schmitt R, Hass R. Human MSC-derived exosomes reduce cellular senescence in renal epithelial cells. Int J Mol Sci. 2021;22:24.
   Web of Science ®Google Scholar
• Dan QQ, Chen L, Shi LL, Zhou X, Wang TH, Liu H. Urine-derived mesenchymal stem cells-derived exosomes enhances survival and proliferation of aging retinal ganglion cells. BMC Mol Cell Biol. 2023;24(1):8.
   PubMed Web of Science ®Google Scholar
• Yang G, Chen H, Chen Q, et al. Injury-induced interleukin-1 alpha promotes Lgr5 hair follicle stem cells de novo regeneration and proliferation via regulating regenerative microenvironment in mice. Inflamm Regen. 2023;43(1):14.
   PubMed Web of Science ®Google Scholar
• Liu S, Zhang N. Narrative review of exosomes: novel players in vascular calcification of chronic kidney disease. Ann Palliat Med. 2021;10(12):13002–13008.
   PubMed Web of Science ®Google Scholar
• Qin Z, Liao R, Xiong Y, et al. A narrative review of exosomes in vascular calcification. Ann Transl Med. 2021;9(7):579.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Li P, Goodwin AJ, et al. Exosomes from endothelial progenitor cells improve the outcome of a murine model of sepsis. Mol Ther. 2018;26(5):1375–1384.
   PubMed Web of Science ®Google Scholar
• Wei W, Guo X, Gu L, et al. Bone marrow mesenchymal stem cell exosomes suppress phosphate-induced aortic calcification via SIRT6-HMGB1 deacetylation. Stem Cell Res Ther. 2021;12(1):235.
   PubMed Web of Science ®Google Scholar
• Yea JH, Yoon YM, Lee JH, Yun CW, Lee SH. Exosomes isolated from melatonin-stimulated mesenchymal stem cells improve kidney function by regulating inflammation and fibrosis in a chronic kidney disease mouse model. J Tissue Eng. 2021;12:20417314211059624.
   Web of Science ®Google Scholar
• Jin J, Qian F, Zheng D, He W, Gong J, He Q. Mesenchymal stem cells attenuate renal fibrosis via exosomes-mediated delivery of microRNA Let-7i-5p antagomir. Int J Nanomed. 2021;16:3565–3578.
   PubMed Web of Science ®Google Scholar
• Liang M, Zhang D, Zheng D, He W, Jin J. Exosomes from miR-374a-5p-modified mesenchymal stem cells inhibit the progression of renal fibrosis by regulating MAPK6/MK5/YAP axis. Bioengineered. 2022;13(2):4517–4527.
   PubMed Web of Science ®Google Scholar
• Wu P, Tang Y, Jin C, et al. Neutrophil membrane engineered HucMSC sEVs alleviate cisplatin-induced AKI by enhancing cellular uptake and targeting. J Nanobiotechnol. 2022;20(1):353.
   PubMed Web of Science ®Google Scholar
• Wang B, Zhang A, Wang H, et al. miR-26a limits muscle wasting and cardiac fibrosis through exosome-mediated microRNA transfer in chronic kidney disease. Theranostics. 2019;9(7):1864–1877.
   PubMed Web of Science ®Google Scholar
• Mo M, Zhou Y, Li S, Wu Y. Three-dimensional culture reduces cell size by increasing vesicle excretion. Stem Cells. 2018;36(2):286–292.
   PubMed Web of Science ®Google Scholar
• Yang Y, Geng X, Chi K, et al. Ultrasound enhances the therapeutic potential of mesenchymal stem cells wrapped in greater omentum for aristolochic acid nephropathy. Stem Cell Res Ther. 2021;12(1):261.
   PubMed Web of Science ®Google Scholar
• Vanholder R, Schepers E, Pletinck A, Nagler EV, Glorieux G. The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review. J Am Soc Nephrol. 2014;25(9):1897–1907.
   PubMed Web of Science ®Google Scholar
• Niwa T. Removal of protein-bound uraemic toxins by haemodialysis. Blood Purif. 2013;35(Suppl 2):20–25.
   PubMedGoogle Scholar
• Wang W, Liu X, Wang W, et al. The effects of indoxyl sulfate on human umbilical cord-derived mesenchymal stem cells in vitro. Cell Physiol Biochem. 2016;38(1):401–414.
   PubMedGoogle Scholar